Quantified
MARCH 2, 2023
Sales enablement is not just a buzzword. Companies of all sizes and industries see results when they have concerted programs and efforts supporting growth and training. After two years of these approaches, organizations see a 48% higher customer engagement rate. Most companies are shifting toward including dedicated sales enablement roles or programs in their organization, but many have yet to make the shift.
Fierce Pharma
MARCH 1, 2023
After wild pandemic ride, is Novavax destined to be the little engine that couldn’t?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medico Reach
MARCH 2, 2023
The healthcare sector is one of the fastest-growing industries. It is now adapting to new changes and implementing new technologies like artificial intelligence to enhance the patient experience. A compound annual growth rate (CAGR) of 12.25% is a testament to the healthcare segment’s exponential and steady rise. So, as a business in this domain, you must leverage hi-tech solutions to capitalize on the budding market.
MedCity News
MARCH 3, 2023
As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes. The key to this is integration into the clinical workflow.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
European Pharmaceutical Review
MARCH 1, 2023
Large RNA is rapidly emerging as a new class of therapeutics. Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine.
Fierce Pharma
MARCH 1, 2023
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit aliu Wed, 03/01/2023 - 10:03
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 2, 2023
Despite ketamine-assisted therapy being approved for treating several mental health conditions, it’s generally not covered by insurance or employers. Though that likely won’t always be the case, as psychedelics gather more research and employers notice the benefits for their workplaces.
European Pharmaceutical Review
FEBRUARY 28, 2023
What are the key data integration challenges faced in labs? At the risk of citing a circular issue, I would say two key challenges are both lack of data standards and a saturation of data standards. Other challenges include proprietary data formats, lack of up-to‑date equipment and inconsistent datasets. An important aspect of data integration is having different datasets in the same format (or at least a format that can be converted to match the other).
Fierce Pharma
FEBRUARY 28, 2023
FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv kdunleavy Tue, 02/28/2023 - 18:55
Medgadget
FEBRUARY 27, 2023
Researchers at Northwestern University have developed a wearable that can detect when someone is talking or singing, and tallies this information up to provide a warning when the wearer might be at risk of vocal fatigue. Overusing your voice in a short space of time can lead to vocal fatigue and even injury. This technology is useful for patients with vocal disorders, but also for people who rely on their voices a lot, such as singers, politicians, and teachers.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
FEBRUARY 26, 2023
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.
Healthcare Success
FEBRUARY 27, 2023
ChatGPT is an artificial intelligence chatbot that can have human-like conversations, translate, and provide users with information. It can also write good content. Like, really good. And now that Google has openly stated, “Appropriate use of AI or automation is not against our guidelines,” it begs the question: Should we use it to produce healthcare content?
Fierce Pharma
MARCH 1, 2023
Eli Lilly slashes insulin prices by 70%, caps out-of-pocket costs in major access overhaul fkansteiner Wed, 03/01/2023 - 08:40
Pharmaceutical Technology
MARCH 2, 2023
The US Food and Drug Administration (FDA) has approved Reata Pharmaceuticals ’ oral, once-daily medication SKYCLARYS (omaveloxolone) to treat Friedreich’s ataxia patients. SKYCLARYS is indicated to treat the ultra-rare, inherited neurodegenerative disorder in 16 years and above-aged adults and adolescents in the US. SKYCLARYS is the first approved treatment in Friedrich’s Ataxia and marks a milestone for drug development in this complex disease.
MedCity News
MARCH 3, 2023
James Comer (R-Ky), House Committee on Oversight and Accountability chairman, sent letters to the Office of Personnel Management, Centers for Medicare and Medicaid Services and the Defense Health Agency asking for documents that show how PBMs’ practices are affecting federal government healthcare programs. In addition, he sent letters to CVS Caremark, Express Scripts and OptumRx, asking them to provide information on their tactics.
European Pharmaceutical Review
FEBRUARY 28, 2023
The largest cell therapy trial to date for chronic heart failure due to low ejection fraction (EF), has shown that mesenchymal precursor cells (MPCs) have potential for the first time to address inflammation. “This study examined the effects of [MPCs] a specific type of stem cell obtained from the bone marrow of healthy adult donors,” the study’s lead author, Dr Emerson C Perin, PhD, FACC, Medical Director at The Texas Heart Institute shared with EPR.
Fierce Pharma
FEBRUARY 28, 2023
Merck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer aliu Tue, 02/28/2023 - 09:40
Nixon Gwilt Law
FEBRUARY 27, 2023
Late Friday (February 24, 2023), the US Drug Enforcement Agency (DEA) released a proposed rule to make permanent some of the flexibilities allowed during the Public Health Emergency (PHE) for telemedicine companies whose providers prescribe controlled substances. Keep reading this timely post to find out: What these proposed changes are; How they will impact your telemedicine business; and Where (and how) stakeholders can weigh in on the DEA’s proposal in the 30-day comment period.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
FEBRUARY 26, 2023
Lucira Health now has the first FDA authorized diagnostic that detects the novel coronavirus and influenza in a single test. But the regulatory decision comes too late for the diagnostics developer, which has filed for bankruptcy protection.
Spotio
FEBRUARY 27, 2023
Every sales manager wants a full pipeline. But generating more sales is only part of the equation. While sales effectiveness does well to improve conversions, there’s another component that should be a priority: sales efficiency. Sales efficiency is the key to not only generating more sales for your business but also streamlining your sales processes so that you get more sales, faster.
Fierce Pharma
MARCH 3, 2023
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices kdunleavy Fri, 03/03/2023 - 10:38
European Pharmaceutical Review
MARCH 1, 2023
In a recent study, Massachusetts Institute of Technology (MIT) researchers developed a new purification method to cut the costs of manufacturing protein drugs. The engineers used bioconjugate-functionalised nanoparticles to quickly and inexpensively isolate proteins from a bioreactor. Producing biologics by isolating proteins Biologics like antibodies and other protein-based drugs are produced by living cells such as yeast in large bioreactors.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
MARCH 3, 2023
In the post-Roe environment of fear and uncertainty, femtech companies should actively review their data collection practices to ensure they are only collecting the minimum amount of data necessary for the app to function. Recent studies have shown that accurate women’s health predictions can be made by some companies that collect far less data than their competitors.
Clarivate
MARCH 1, 2023
International research collaboration is critical to scientific discovery. Just as the research landscape grows in complexity, the landscape of collaboration continuously changes, making it more challenging to track progress. At the University of South Florida (USF), the fastest rising university in the U.S. News & World Report’s U.S. rankings, maintaining the pace of global engagement, high-impact research and innovation is supported with a metrics dashboard that informs strategic planning a
Fierce Pharma
MARCH 1, 2023
Reata scores first FDA approval in its 21-year history, pushing rare disease drug over finish line kdunleavy Wed, 03/01/2023 - 10:31
Legacy MEDSearch
FEBRUARY 28, 2023
ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced that primary endpoint results from the RADIANCE II pivotal trial were published in the Journal of the American Medical Association (JAMA). Study results showed that the Paradise Ultrasound Renal Denervation (uRDN) System successfully reduced blood pressure compared to sham.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
MedCity News
MARCH 3, 2023
Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments. True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells.
Clarivate
FEBRUARY 28, 2023
Through a comparative analysis of published LHON prevalence data and real-world evidence, this article describes a study using multiple Clarivate TM data sets to better understand disease pathology and current drug utilization for this condition. The study was conducted collaboratively by Clarivate Senior Science Editor Shyama Ghosh, Senior Epidemiologist Shilpa Thakur, Managing Editor Stephen DuPraw and Senior Director Evelyn Davila.
Fierce Pharma
MARCH 2, 2023
With 2nd chance at FDA approval, BioMarin preps for hemophilia gene therapy launch in US zbecker Thu, 03/02/2023 - 16:28
European Pharmaceutical Review
MARCH 2, 2023
Last year was another challenging one for the pharmaceutical industry. On top of residual pandemic-related challenges and supply chain issues, the ever-adapting regulatory environment has continued to set new standards and enforce new requirements. This article explores some of the most notable developments of 2022, and areas that are likely to be a growing focus for data-driven transformation in 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content